Advertisement

Functional Assessment of Fibroblast Heterogeneity by the Cell-Surface Glycoprotein Thy-1

  • Carolyn J. Baglole
  • Terry J. Smith
  • David Foster
  • Patricia J. Sime
  • Steve Feldon
  • Richard P. Phipps
Part of the Biotechnology Intelligence Unit book series (BIOIU)

Abstract

Fibroblasts are a heterogeneous population of structural cells whose primary function is the production of extracellular matrix for normal tissue maintenance and repair. However, fibroblasts provide much more than structural support as they synthesize and respond to many different cytokines and lipid mediators and are intimately involved in the processes of inflammation. It is now appreciated that fibroblasts exhibit phenotypic heterogeneity, differing not only between organ systems, but also within a given anatomical site. Subtypes of fibroblasts can be identified by the expression of markers such as Thy-1, a cell surface glycoprotein of unknown function. Initial characterization of fibroblasts as Thy-1+ or Thy-1 can be performed by immunofluorescence or flow cytometry. They can be sorted according to their expression of Thy-1 by fluorescence-activated cell sorting (FACS), cloning and/or magnetic beading, yielding greater than 99% purity. Fibroblasts that are separated into Thy-1+ and Thy-1 subsets exhibit differences in their morphological, immunological and proliferative responses and ability to differentiate into a-smooth muscle actin-expressing myofibroblasts and adipocyte-like lipofibroblasts, key cells for wound healing and fibrotic disorders. The identification of Thy-1 as a surface marker by which to separate fibroblast subtypes has yielded vital insight into diseases such as scarring and wound healing and highlights the concept of fibroblast heterogeneity. Future research into fibroblast subsets may lead to the tissue-specific treatment of disease such as idiopathic pulmonary fibrosis and Graves’ ophthalmopathy.

Keywords

Focal Adhesion Idiopathic Pulmonary Fibrosis Connective Tissue Growth Factor Lung Fibroblast Human Lung Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    White ES, Lazar MH, Thannickal VJ. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 2003; 201(3):343–354.PubMedCrossRefGoogle Scholar
  2. 2.
    Korn JH, Thrall RS, Wilbur DC et al. Fibroblast heterogeneity: Clonal selection of fibroblasts as a model for fibrotic disease. In: Phipps RP, ed. Pulmonary fibroblast heterogeneity. Boca Raton: CRC Press Inc., 1992:119–133.Google Scholar
  3. 3.
    Kaufman J, Sime PJ, Phipps RP. Expression of CD154 (CD40 ligand) by human lung fibroblasts: Differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol 2004; 172(3):1862–1871.PubMedGoogle Scholar
  4. 4.
    Gabbiani G. The role of contractile proteins in wound healing and fibrocontractive diseases. Methods Achiev Exp Pathol 1979; 9:187–206.PubMedGoogle Scholar
  5. 5.
    Breen E, Cutroneo KR. Biochemical and molecular aspects of pulmonary fibroblast heterogeneity. In: Phipps RP, ed. Pulmonary fibroblast heterogeneity. Boca Raton: CRC Press Inc., 1992:27–53.Google Scholar
  6. 6.
    Smith TJ, Sempowski GD, Berenson CS et al. Human thyroid fibroblasts exhibit a distinctive phenotype in culture: Characteristic ganglioside profile and functional CD40 expression. Endocrinology 1997; 138(12):5576–5588.PubMedCrossRefGoogle Scholar
  7. 7.
    Smith TJ, Koumas L, Gagnon A et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2002; 87(1):385–392.PubMedCrossRefGoogle Scholar
  8. 8.
    Bordin S, Page RC, Narayanan AS. Heterogeneity of normal human diploid fibroblasts: Isolation and characterization of one phenotype. Science 1984; 223(4632):171–173.PubMedCrossRefGoogle Scholar
  9. 9.
    Phipps RP, Penney DP, Keng P et al. Characterization of two major populations of lung fibroblasts: Distinguishing morphology and discordant display of Thy 1 and class II MHC. Am J Respir Cell Mol Biol 1989; 1(1):65–74.PubMedGoogle Scholar
  10. 10.
    McIntosh JC, Hagood JS, Richardson TL et al. Thy1 (+) and (−) lung fibrosis subpopulations in LEW and F344 rats. Eur Respir J 1994; 7(12):2131–2138.PubMedCrossRefGoogle Scholar
  11. 11.
    Koumas L, King AE, Critchley HO et al. Fibroblast heterogeneity: Existence of functionally distinct Thy 1(+) and Thy 1(−) human female reproductive tract fibroblasts. Am J Pathol 2001; 159(3):925–935.PubMedGoogle Scholar
  12. 12.
    Koumas L, Phipps RP. Differential COX localization and PG release in Thy-1(+) and Thy-1(−) human female reproductive tract fibroblasts. Am J Physiol Cell Physiol 2002; 283(2):C599–608.PubMedGoogle Scholar
  13. 13.
    Lee WS, Jain MK, Arkonac BM et al. Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res 1998; 82(8):845–851.PubMedGoogle Scholar
  14. 14.
    Froncek MJ, Derdak S, Felch ME et al. Cellular and molecular characterization of Thy-1+ and Thy-1 murine lung fibroblasts. In: Phipps RP, ed. Pulmonary Fibroblast Heterogeneity. Boca Raton: CRC Press Inc., 1992:135–198.Google Scholar
  15. 15.
    Zhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 2004; 165(2):659–669.PubMedGoogle Scholar
  16. 16.
    Haeryfar SM, Hoskin DW. Thy-1: More than a mouse pan-T cell marker. J Immunol 2004; 173(6):3581–3588.PubMedGoogle Scholar
  17. 17.
    Pont S. Thy-1: A lymphoid cell subset marker capable of delivering an activation signal to mouse T lymphocytes. Biochimie 1987; 69(4):315–320.PubMedCrossRefGoogle Scholar
  18. 18.
    Baglole CJ, Reddy SY, Pollock SJ et al. Phenotypic characterization and isolation of primary fibroblast strains and their derivative subsets. Methods in Molecular Medicine, Fibrosis: Experimental Approaches and Protocols. Totowa: Humana; In Press.Google Scholar
  19. 19.
    Penney DP, Keng PC, Derdak S et al. Morphologic and functional characteristics of subpopulations of murine lung fibroblasts grown in vitro. Anat Rec 1992; 232(3):432–443.PubMedCrossRefGoogle Scholar
  20. 20.
    Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996; 167(2):290–296.PubMedCrossRefGoogle Scholar
  21. 21.
    Smith TJ, Sempowski GD, Wang HS et al. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab 1995; 80(9):2620–2625.PubMedCrossRefGoogle Scholar
  22. 22.
    Borrello MA, Phipps RP. Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol 1996; 173(2):198–206.PubMedCrossRefGoogle Scholar
  23. 23.
    Phipps RP, Borrello MA, Blieden TM. Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res 1997; 32(1 Pt 2):159–165.PubMedCrossRefGoogle Scholar
  24. 24.
    Hagood JS, Mangalwadi A, Guo B et al. Concordant and discordant interleukin-1-mediated signaling in lung fibroblast thy-1 subpopulations. Am J Respir Cell Mol Biol 2002; 26(6):702–708.PubMedGoogle Scholar
  25. 25.
    Koumas L, Smith TJ, Feldon S et al. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 2003; 163(4):1291–1300.PubMedGoogle Scholar
  26. 26.
    Koumas L, Smith TJ, Phipps RP. Fibroblast subsets in the human orbit: Thy-1+ and Thy-1-subpopulations exhibit distinct phenotypes. Eur J Immunol 2002; 32(2):477–485.PubMedCrossRefGoogle Scholar
  27. 27.
    Fries KM, Felch ME, Phipps RP. Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am J Respir Cell Mol Biol 1994; 11(5):552–560.PubMedGoogle Scholar
  28. 28.
    Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev 2003; 24(6):802–835.PubMedCrossRefGoogle Scholar
  29. 29.
    Sempowski GD, Rozenblit J, Smith TJ et al. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 1998; 274(3 Pt 1):C707–714.PubMedGoogle Scholar
  30. 30.
    Mukaida N. Interleukin-8: An expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72(4):391–398.PubMedGoogle Scholar
  31. 31.
    Zhang Y, Cao HJ, Graf B et al. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J Immunol 1998; 160(3):1053–1057.PubMedGoogle Scholar
  32. 32.
    Wang HS, Cao HJ, Winn VD et al. Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation. J Biol Chem 1996; 271(37):22718–22728.PubMedCrossRefGoogle Scholar
  33. 33.
    Kehry MR. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. J Immunol 1996; 156(7):2345–2348.PubMedGoogle Scholar
  34. 34.
    Noelle RJ. CD40 and its ligand in host defense. Immunity 1996; 4(5):415–419.PubMedCrossRefGoogle Scholar
  35. 35.
    Cao HJ, Wang HS, Zhang Y et al. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem 1998; 273(45):29615–29625.PubMedCrossRefGoogle Scholar
  36. 36.
    Roy SG, Nozaki Y, Phan SH. Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol 2001; 33(7):723–734.PubMedCrossRefGoogle Scholar
  37. 37.
    Liu T, Dhanasekaran SM, Jin H et al. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 2004; 164(4):1315–1326.PubMedGoogle Scholar
  38. 38.
    Sime PJ, O’Reilly KM. Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment. Clin Immunol 2001; 99(3):308–319.PubMedCrossRefGoogle Scholar
  39. 39.
    Moodley YP, Caterina P, Scaffidi AK et al. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis. J Pathol 2004; 202(4):486–495.PubMedCrossRefGoogle Scholar
  40. 40.
    Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157(1):199–203.PubMedGoogle Scholar
  41. 41.
    Ramos C, Montano M, Garcia-Alvarez J et al. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001; 24(5):591–598.PubMedGoogle Scholar
  42. 42.
    Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 2004; 15(4):255–273.PubMedCrossRefGoogle Scholar
  43. 43.
    Hagood JS, Miller PJ, Lasky JA et al. Differential expression of platelet-derived growth factor-alpha receptor by Thy-1(−) and Thy-1(+) lung fibroblasts. Am J Physiol 1999; 277(1 Pt 1):L218–224.PubMedGoogle Scholar
  44. 44.
    Bonner JC, Lindroos PM, Rice AB et al. Induction of PDGF receptor-alpha in rat myofibroblasts during pulmonary fibrogenesis in vivo. Am J Physiol 1998; 274(1 Pt 1):L72–80.PubMedGoogle Scholar
  45. 45.
    Silvera MR, Phipps RP. Synthesis of interleukin-1 receptor antagonist by Thy-1+ and Thy-1− murine lung fibroblast subsets. J Interferon Cytokine Res 1995; 15(1):63–70.PubMedCrossRefGoogle Scholar
  46. 46.
    Watts KL, Spiteri MA. Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism. Am J Physiol Lung Cell Mol Physiol 2004; 287(6):L1323–L1332.PubMedCrossRefGoogle Scholar
  47. 47.
    Hagood JS, Lasky JA, Nesbitt JE et al. Differential expression, surface binding, and response to connective tissue growth factor in lung fibroblast subpopulations. Chest 2001; 120(1 Suppl):64S–66S.PubMedCrossRefGoogle Scholar
  48. 48.
    Barker TH, Grenett HE, MacEwen MW et al. Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity. Exp Cell Res 2004; 295(2):488–496.PubMedCrossRefGoogle Scholar
  49. 49.
    Barker TH, Pallero MA, MacEwen MW et al. Thrombospondin-1-induced focal adhesion disassembly in fibroblasts requires Thy-1 surface expression, lipid raft integrity, and Src activation. J Biol Chem 2004; 279(22):23510–23516.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2006

Authors and Affiliations

  • Carolyn J. Baglole
    • 5
  • Terry J. Smith
    • 1
  • David Foster
    • 2
  • Patricia J. Sime
    • 3
  • Steve Feldon
    • 4
  • Richard P. Phipps
    • 5
  1. 1.Division of Molecular MedicineHarbor-UCLA Medical CenterTorranceUSA
  2. 2.Department of Obstetrics and GynecologyUniversity of Rochester School of Medicine and DentistryRochesterUSA
  3. 3.Division of Pulmonary and Critical Care MedicineUniversity of Rochester School of Medicine and DentistryRochesterUSA
  4. 4.Department of OphthalmologyUniversity of Rochester School of Medicine and DentistryRochesterUSA
  5. 5.Department of Environmental MedicineUniversity of Rochester School of Medicine and DentistryRochesterUSA

Personalised recommendations